Table 2.
Observed locations and findings | Density of tumor infiltrating CD8+ T cells and variables | DSS | OS | RFS | |||
---|---|---|---|---|---|---|---|
Survival rate (%) | Log‐rank test (P‐value) | Survival rate (%) | Log‐rank test (P‐value) | Survival rate (%) | Log‐rank test (P‐value) | ||
Stroma in the center of the tumor (/×400) (range 0‐200) | Cutoff point = 25 cells | ||||||
High; ≧25 | 92.0 | P = 0.45 | 85.5 | P = 0.34 | 56.5 | P = 0.25 | |
Low; <25 | 88.3 | 80.4 | 65.5 | ||||
Parenchyma in the center of the tumor (/×400) (range 0‐200) | Cutoff point = 9 cells | ||||||
High; ≧9 | 92.6 | P = 0.41 | 85.0 | P = 0.47 | 63.8 | P = 0.74 | |
Low; <9 | 88.4 | 81.2 | 61.5 | ||||
Stroma in the invading tumor edge (/×400) (range 0‐200) | Cutoff point = 64 cells | ||||||
High; ≧64 | 95.5 | P = 0.10 | 90.6 | P = 0.05 | 64.6 | P = 0.66 | |
Low; <64 | 86.8 | 78.3 | 61.1 | ||||
Parenchyma in the invading tumor edge (/×400) (range 0‐200) | Cutoff point = 13 cells | ||||||
High; ≧13 | 100.0 | P < 0.01 | 93.6 | P < 0.01 | 71.6 | P = 0.07 | |
Low; <13 | 83.6 | 76.1 | 56.9 | ||||
Periphery of the tumor (/×400) (range 0‐200) | Cutoff point = 84 cells | ||||||
High; ≧84 | 93.2 | P = 0.32 | 85.9 | P = 0.34 | 77.1 | P < 0.01 | |
Low; <84 | 87.9 | 80.7 | 55.1 | ||||
Clinical findings | Gender | ||||||
Male | 90.7 | P = 0.65 | 82.8 | P = 0.85 | 65.9 | P = 0.26 | |
Female | 88.3 | 82.0 | 57.8 | ||||
Age (years) | |||||||
<67 | 98.2 | P < 0.01 | 94.6 | P < 0.01 | 73.7 | P = 0.02 | |
≧67 | 83.4 | 73.7 | 54.1 | ||||
Tumor site | |||||||
Tongue/Floor of mouth | 94.2 | P = 0.01 | 88.7 | P < 0.01 | 66.4 | P = 0.10 | |
Others | 81.3 | 70.7 | 54.5 | ||||
cT stage | |||||||
cT1 | 97.7 | P = 0.01 | 95.6 | P < 0.01 | 69.0 | P = 0.10 | |
cT2 | 87.9 | 80.0 | 62.1 | ||||
cT3/4 | 74.5 | 55.6 | 42.9 | ||||
cN stage | |||||||
cN0 | 95.2 | P < 0.01 | 87.3 | P < 0.01 | 65.3 | P = 0.14 | |
cN1/2 | 69.6 | 64.1 | 51.4 | ||||
cTNM stage | |||||||
Stage I | 100.0 | P = 0.01 | 97.1 | P < 0.01 | 71.1 | P = 0.12 | |
Stage II | 91.5 | 82.9 | 63.6 | ||||
Stage III/IV | 73.5 | 63.3 | 49.5 | ||||
Operative method | |||||||
Peroral tumor excision | 96.6 | P < 0.01 | 89.3 | P < 0.01 | 63.3 | P = 0.61 | |
Primary tumor excision with neck dissection | 76.0 | 68.6 | 60.2 | ||||
Pathological findings | Histologic grade | ||||||
Grade 1 | 94.5 | P = 0.15 | 87.0 | P = 0.26 | 70.3 | P < 0.01 | |
Grade 2 | 84.5 | 77.0 | 55.1 | ||||
Grade 3 | 80.0 | 80.0 | 20.0 | ||||
pT stage | |||||||
pT1 | 98.5 | P < 0.01 | 93.7 | P < 0.01 | 65.8 | P = 0.01 | |
pT2 | 88.3 | 78.4 | 66.1 | ||||
pT3/4 | 56.3 | 47.1 | 35.3 | ||||
pN stage | |||||||
pN0 | 96.2 | P < 0.01 | 86.9 | P < 0.01 | 73.8 | P < 0.01 | |
pN1/2 | 62.7 | 62.7 | 14.8 | ||||
pTNM stage | |||||||
Stage I | 98.2 | P < 0.01 | 92.7 | P < 0.01 | 74.0 | P < 0.01 | |
Stage II | 95.2 | 83.4 | 77.1 | ||||
Stage III/IV | 68.6 | 63.7 | 24.7 | ||||
Lymphovascular invasion | |||||||
Absence | 91.2 | P = 0.22 | 85.2 | P = 0.09 | 66.1 | P = 0.03 | |
Presence | 82.4 | 69.3 | 43.0 | ||||
Perineural invasion | |||||||
Absence | 91.9 | P < 0.01 | 85.4 | P < 0.01 | 65.5 | P < 0.01 | |
Presence | 66.1 | 53.8 | 30.8 | ||||
Surgical margin status | |||||||
Negative | 89.5 | P = 0.73 | 84.0 | P = 0.24 | 64.1 | P = 0.38 | |
Positive | 90.9 | 67.1 | 42.7 |
Bold indicates P < 0.05.